Pliant Therapeutics, Inc.
US ˙ NasdaqGS ˙ US7291391057

Introduction

This page provides a comprehensive analysis of the known insider trading history of David E I Pyott. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate David E I Pyott has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ALNY / Alnylam Pharmaceuticals, Inc. Director 911
US:BMRN / BioMarin Pharmaceutical Inc. Director 49,750
US:PLRX / Pliant Therapeutics, Inc. Director 13,286
US:AVY / Avery Dennison Corporation Director 0
Chairman of the Board and CEO, Director 0
US:EW / Edwards Lifesciences Corporation Director 1,874
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by David E I Pyott. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases PLRX / Pliant Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in PLRX / Pliant Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PLRX / Pliant Therapeutics, Inc. Insider Trades
Insider Sales PLRX / Pliant Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in PLRX / Pliant Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PLRX / Pliant Therapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by David E I Pyott as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-05-12 2025-05-08 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 775 911 569.85
2025-03-25 2025-03-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7,440 136 -98.20 299.00 -2,224,560 40,664
2025-03-25 2025-03-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7,440 7,576 5,470.59 88.95 661,788 673,885
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7,470 136 -98.21 222.00 -1,658,340 30,192
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7,420 7,606 -49.38 221.00 -1,639,820 1,680,926
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -17,560 15,026 -53.89 220.00 -3,863,200 3,305,720
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7,470 32,586 29.74 71.99 537,765 2,345,866
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7,420 25,116 41.93 70.20 520,884 1,763,143
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 17,560 17,696 12,911.76 88.95 1,561,962 1,574,059
2024-05-23 2024-05-21 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,720 49,750 10.48
2023-05-24 2023-05-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,190 45,030 10.26
2023-02-27 2023-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 136 136
2022-05-26 2022-05-24 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,980 40,840 13.89
2022-05-20 2022-05-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 5,153 5,153
2022-02-25 2022-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 136 136
2021-07-19 2021-07-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4,032 4,032
2021-07-01 2021-06-29 4/A PLRX PLIANT THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 13,286 13,286
2021-06-30 2021-06-29 4 PLRX PLIANT THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 13,286 13,286
2021-05-27 2021-05-25 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 5,120 35,860 16.66
2021-01-13 2021-01-12 4 PLRX PLIANT THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 26,573 26,573
2020-09-01 2020-08-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
P - Purchase 900 30,740 3.02 78.84 70,955 2,423,520
2020-09-01 2020-08-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
P - Purchase 11,900 29,840 66.33 78.22 930,760 2,333,939
2020-07-06 2020-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4,581 4,581
2020-05-29 2020-05-27 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,300 17,940 31.52
2020-04-24 2020-04-23 4 AVY Avery Dennison Corp
2019 Director RSU Award
M - Exercise -1,414 0 -100.00
2020-04-24 2020-04-23 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,414 18,684 8.19 107.56 152,090 2,009,651
2020-02-05 2020-02-03 4 AVY Avery Dennison Corp
2010 Director Stock Option
M - Exercise -5,027 0 -100.00
2020-02-05 2020-02-03 4 AVY Avery Dennison Corp
Common Stock
S - Sale -5,027 17,270 -22.55 132.72 -667,183 2,292,074
2020-02-05 2020-02-03 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 5,027 22,297 29.11 38.18 191,931 851,299
2019-07-02 2019-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9,000 9,000
2019-06-06 2019-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,430 13,640 48.10
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
2019 Director RSU Award
A - Award 1,414 1,414
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
2018 Director RSU Award
M - Exercise -1,336 0 -100.00
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
M - Exercise -641 0 -100.00
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,336 17,270 8.38 109.63 146,466 1,893,310
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 641 15,934 4.19 109.63 70,273 1,746,844
2018-11-28 2018-11-27 4 AVY Avery Dennison Corp
2009 Director Stock Option
M - Exercise -2,000 0 -100.00
2018-11-28 2018-11-27 4 AVY Avery Dennison Corp
Common Stock
S - Sale -2,000 15,293 -11.57 93.00 -186,000 1,422,249
2018-11-28 2018-11-27 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 2,000 17,293 13.08 20.64 41,280 356,928
2018-06-22 2018-06-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9,000 9,000
2018-06-07 2018-06-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,300 9,210 87.58
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2018 Director RSU Award
A - Award 1,336 1,336
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2017 Director RSU Award
M - Exercise -1,678 0 -100.00
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
M - Exercise -641 641 -50.00
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2015 Director RSU Award
M - Exercise -747 0 -100.00
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,678 15,293 12.32 104.80 175,854 1,602,706
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 641 13,615 4.94 104.80 67,177 1,426,852
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 747 12,974 6.11 104.80 78,286 1,359,675
2017-08-30 2017-08-30 4 AVY Avery Dennison Corp
2008 Director Stock Option
M - Exercise -1,702 0 -100.00
2017-08-30 2017-08-30 4 AVY Avery Dennison Corp
Common Stock
S - Sale -1,702 16,303 -9.45 94.00 -159,988 1,532,482
2017-08-30 2017-08-30 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,702 18,005 10.44 52.12 88,700 938,331
2017-08-30 2017-08-28 4 AVY Avery Dennison Corp
2008 Director Stock Option
M - Exercise -298 1,702 -14.90
2017-08-30 2017-08-28 4 AVY Avery Dennison Corp
Common Stock
S - Sale -298 16,303 -1.80 94.00 -28,012 1,532,482
2017-08-30 2017-08-28 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 298 16,601 1.83 52.12 15,530 865,161
2017-06-08 2017-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 4,910 4,910
2017-06-08 2017-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 2,050 4,910 71.68
2017-06-06 2017-06-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11,250 11,250
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2017 Director RSU Award
A - Award 1,678 1,678
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
M - Exercise -640 1,282 -33.30
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2015 Director RSU Award
M - Exercise -746 747 -49.97
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2014 Director RSU Award
M - Exercise -859 0 -100.00
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 640 16,303 4.09 83.42 53,389 1,359,996
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 746 15,663 5.00 83.42 62,231 1,306,607
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 859 14,917 6.11 83.42 71,658 1,244,376
2016-10-14 2016-10-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 27,900 27,900 37.00 1,032,328 1,032,328
2016-08-09 2016-08-08 4 AVY Avery Dennison Corp
2006 Director Stock Option
M - Exercise -2,000 0 -100.00
2016-08-09 2016-08-08 4 AVY Avery Dennison Corp
Common Stock
S - Sale -2,000 14,058 -12.45 78.61 -157,220 1,105,099
2016-08-09 2016-08-08 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 2,000 16,058 14.23 67.80 135,590 1,088,652
2016-06-08 2016-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 2,220 2,220
2016-06-08 2016-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 760 2,860 36.19
2016-06-07 2016-06-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11,250 11,250
2016-05-02 2016-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
A - Award 1,922 1,922
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
2015 Director RSU Award
M - Exercise -746 1,493 -33.32
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
2014 Director RSU Award
M - Exercise -859 859 -50.00
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
2013 Director RSU Award
M - Exercise -1,015 0 -100.00
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 746 14,058 5.60 72.82 54,324 1,023,704
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 859 13,312 6.90 72.82 62,552 969,380
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,015 12,453 8.87 72.82 73,912 906,827
2016-01-06 2016-01-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 6,100 6,100
2016-01-06 2016-01-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 2,100 2,100
2015-12-22 2015-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25,000 25,000
2015-11-03 2015-11-02 4 AVY Avery Dennison Corp
2005 Director Stock Option
M - Exercise -2,000 0 -100.00
2015-11-03 2015-11-02 4 AVY Avery Dennison Corp
Common Stock
S - Sale -2,000 11,438 -14.88 64.88 -129,760 742,097
2015-11-03 2015-11-02 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 2,000 13,438 17.49 59.46 118,930 799,091
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
2015 Director RSU Award
A - Award 2,239 2,239
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
2014 Director RSU Award
M - Exercise -859 1,718 -33.33
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
2013 Director RSU Award
M - Exercise -1,015 1,015 -50.00
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 859 11,438 8.12 55.84 47,967 638,698
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,015 10,579 10.61 55.84 56,678 590,731
2015-04-28 2015-04-26 4 AVY Avery Dennison Corp
2012 Director Rsu Award
M - Exercise -524 0 -100.00
2015-04-28 2015-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 524 9,564 5.80 51.77 27,127 495,128
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -257,756 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -422,400 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -303,000 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -533,000 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -312,000 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -375,000 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -410,000 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -386,800 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -114,548 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -2,897 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -2,180 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -165,658 0 -100.00
2015-03-19 2015-02-12 4 AGN ALLERGAN INC
Common Stock
G - Gift -114,548 114,548 -50.00
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Restricted Stock Units
M - Exercise -1,379 0 -100.00
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Restricted Stock Units
A - Award 1,379 1,379
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Common Stock
F - Taxes -720 165,659 -0.43 234.00 -168,480 38,764,206
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Common Stock
M - Exercise 1,379 166,379 0.84
2014-12-02 2014-12-01 4 AVY Avery Dennison Corp
Common Stock Units - DDECP
A - Award 1,119 39,412 2.92
2014-05-13 2014-05-09 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 1,874 1,874
2014-05-13 2014-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2,342 53,582 4.57
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
2013 Director RSU Award
M - Exercise -1,015 2,030 -33.33
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
Common Stock Units - DDECP
A - Award 1,289 37,754 3.54
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
2014 Director RSU Award
A - Award 2,577 2,577
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,015 9,040 12.65 48.50 49,228 438,440
2014-04-29 2014-04-28 4 AVY Avery Dennison Corp
2011 Director RSU
M - Exercise -391 0 -100.00
2014-04-29 2014-04-28 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 391 8,025 5.12 48.82 19,089 391,780
2014-04-29 2014-04-26 4 AVY Avery Dennison Corp
2012 Director RSU Award
M - Exercise -523 524 -49.95
2014-04-29 2014-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 523 7,634 7.35 48.70 25,473 371,814
2014-02-25 2014-02-21 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
A - Award 257,756 257,756 125.07 32,237,543 32,237,543
2014-02-13 2014-02-12 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -252,000 0 -100.00
2014-02-13 2014-02-12 4 AGN ALLERGAN INC
Common Stock
S - Sale -252,000 165,000 -60.43 123.12 -31,025,560 20,314,354
2014-02-13 2014-02-12 4 AGN ALLERGAN INC
Common Stock
M - Exercise 252,000 417,000 152.73 36.15 9,109,800 15,074,550
2013-12-03 2013-12-01 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1,278 36,046 3.68
2013-05-17 2013-05-15 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 2,250 2,250
2013-05-17 2013-05-15 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2,811 51,240 5.80
2013-05-02 2013-05-01 4 AVY Avery Dennison Corp
2013 Director RSU Award
A - Award 3,045 3,045
2013-05-02 2013-05-01 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 774 34,313 2.31
2013-05-01 2013-05-01 4 EW Edwards Lifesciences Corp
Common Stock
P - Purchase 3,000 48,429 6.60 62.95 188,850 3,048,606
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
2012 Director RSU
M - Exercise -522 1,047 -33.27
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
2011 Director RSU
M - Exercise -390 391 -49.94
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 522 7,111 7.92 41.52 21,671 295,213
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 390 6,589 6.29 41.52 16,191 273,542
2013-04-23 2013-04-22 4 AVY Avery Dennison Corp
2010 Director RSU
M - Exercise -436 0 -100.00
2013-04-23 2013-04-22 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 436 6,199 7.57 40.85 17,811 253,229
2013-04-02 2013-04-01 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 983 33,539 3.02
2013-02-22 2013-02-21 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
A - Award 303,000 303,000
2012-12-20 2012-12-19 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1,233 32,556 3.94
2012-10-05 2012-10-05 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -307,956 0 -100.00
2012-10-05 2012-10-05 4 AGN ALLERGAN INC
Common Stock
S - Sale X -307,956 229,096 -57.34 93.72 -28,862,868 21,471,794
2012-10-05 2012-10-05 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 307,956 537,052 134.42 41.24 12,700,105 22,148,024
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -101,421 307,956 -24.77
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -90,623 409,377 -18.12
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -119,000 0 -100.00
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
S - Sale X -101,421 229,096 -30.69 93.71 -9,504,486 21,469,319
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 101,421 330,517 44.27 41.24 4,182,602 13,630,521
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 90,623 229,096 65.44 41.24 3,737,293 9,447,919
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 119,000 138,473 611.10 30.12 3,584,875 4,171,499
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
S - Sale X -206,923 19,473 -91.40 93.74 -19,396,714 1,825,376
2012-10-05 2012-09-21 4 AGN ALLERGAN INC
Common Stock
G - Gift 19,473 226,396 9.41
2012-10-05 2012-09-21 4 AGN ALLERGAN INC
Common Stock
G - Gift -19,473 165,000 -10.56
2012-10-02 2012-09-28 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1,179 31,323 3.91
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise -3,520 0 -100.00
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise -3,278 0 -100.00
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Common Stock
S - Sale -6,798 45,429 -13.02 100.65 -684,199 4,572,297
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise 3,278 52,227 6.70 24.42 80,049 1,275,383
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise 3,520 48,949 7.75 22.72 79,957 1,111,877
2012-07-02 2012-06-29 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1,304 30,144 4.52
2012-05-18 2012-05-16 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
G - Gift 312,000 312,000
2012-05-18 2012-05-16 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
G - Gift -312,000 0 -100.00
2012-05-14 2012-05-11 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 1,890 1,890
2012-05-14 2012-05-11 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2,361 45,429 5.48
2012-04-30 2012-04-27 4 AVY Avery Dennison Corp
2011 Director RSU
M - Exercise -389 781 -33.25
2012-04-30 2012-04-27 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 389 5,763 7.24 32.36 12,586 186,462
2012-04-30 2012-04-26 4 AVY Avery Dennison Corp
2012 Director Stock Option
A - Award 6,318 6,318
2012-04-30 2012-04-26 4 AVY Avery Dennison Corp
2012 Director RSU Award
A - Award 1,569 1,569
2012-04-23 2012-04-20 4 AVY Avery Dennison Corp
2010 Director RSU
M - Exercise -437 436 -50.06
2012-04-23 2012-04-20 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 437 5,374 8.85 31.33 13,691 168,367
2012-04-02 2012-03-30 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1,338 28,840 4.86
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
A - Award 312,000 312,000
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Common Stock
A - Award 2,045 185,563 1.11
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Common Stock
F - Taxes -955 183,518 -0.52 87.91 -83,954 16,133,067
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Common Stock
A - Award 165,000 184,473 847.33
2012-02-16 2012-02-14 4 AGN ALLERGAN INC
Common Stock
F - Taxes -12,869 18,383 -41.18 88.10 -1,133,823 1,619,634
2012-01-18 2012-01-18 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise X -20,000 0 -100.00
2012-01-18 2012-01-18 4 EW Edwards Lifesciences Corp
Common Stock
S - Sale X -20,000 43,068 -31.71 76.95 -1,539,060 3,314,212
2012-01-18 2012-01-18 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise X 20,000 63,068 46.44 12.88 257,700 812,631
2010-05-18 2010-05-14 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 796 796
2010-05-18 2010-05-14 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1,987 29,286 7.28
2004-05-17 2004-05-13 4 EW EDWARDS LIFESCIENCES CORP
Common Stock
A - Award 4,000 9,000 80.00
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)